- Home
- MLYS vs HAYW Comparison
MLYS vs HAYW Comparison
Compare MLYS & HAYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- HAYW
- Stock Information
- Founded
- MLYS 2019
- HAYW 1925
- Country
- MLYS United States
- HAYW United States
- Employees
- MLYS N/A
- HAYW N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- HAYW Electronic Components
- Sector
- MLYS Health Care
- HAYW Technology
- Exchange
- MLYS Nasdaq
- HAYW Nasdaq
- Market Cap
- MLYS 3.1B
- HAYW 3.3B
- IPO Year
- MLYS 2023
- HAYW 2021
- Fundamental
- Price
- MLYS $40.00
- HAYW $15.61
- Analyst Decision
- MLYS Strong Buy
- HAYW Hold
- Analyst Count
- MLYS 6
- HAYW 5
- Target Price
- MLYS $42.60
- HAYW $17.33
- AVG Volume (30 Days)
- MLYS 1.3M
- HAYW 1.5M
- Earning Date
- MLYS 11-10-2025
- HAYW 10-29-2025
- Dividend Yield
- MLYS N/A
- HAYW N/A
- EPS Growth
- MLYS N/A
- HAYW 46.31
- EPS
- MLYS N/A
- HAYW 0.60
- Revenue
- MLYS N/A
- HAYW $1,083,088,000.00
- Revenue This Year
- MLYS N/A
- HAYW $5.84
- Revenue Next Year
- MLYS N/A
- HAYW $5.39
- P/E Ratio
- MLYS N/A
- HAYW $25.96
- Revenue Growth
- MLYS N/A
- HAYW 8.77
- 52 Week Low
- MLYS $8.24
- HAYW $11.10
- 52 Week High
- MLYS $44.80
- HAYW $16.87
- Technical
- Relative Strength Index (RSI)
- MLYS 53.93
- HAYW 54.62
- Support Level
- MLYS $41.74
- HAYW $14.93
- Resistance Level
- MLYS $44.60
- HAYW $15.66
- Average True Range (ATR)
- MLYS 2.22
- HAYW 0.41
- MACD
- MLYS -0.83
- HAYW 0.03
- Stochastic Oscillator
- MLYS 46.44
- HAYW 81.82
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About HAYW Hayward Holdings Inc.
Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.1 billion in revenue in 2024.